| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |